Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN